Results 281 to 290 of about 77,584 (306)
Some of the next articles are maybe not open access.

[Development of HDAC inhibitors].

Gan to kagaku ryoho. Cancer & chemotherapy, 2010
In the mechanisms of carcinogenesis, it is becoming apparent that not only genetic abnormalities including DNA mutations, but also epigenetic abnormalities are heavily involved. Simultaneously, certain kinds of compounds indicated anti-tumor activity through their epigenetic effects.
openaire   +1 more source

Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells

Nature Reviews Drug Discovery, 2009
Liqing Wang   +2 more
exaly  

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Nature Biotechnology, 2011
Marcus Bantscheff   +2 more
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap   +2 more
exaly  

Home - About - Disclaimer - Privacy